TODAY'S HEADLINES

Teva halts migraine patch sales over burns

Teva Pharmaceuticals is temporarily suspending sales and distribution of its sumatriptan iontophoretic transdermal system (Zecuity) patch for migraines, soon after FDA said it is investigating the risk of serious burns with the use of the patch. Read more

First US cholera vaccine available

FDA approved the first US vaccine for cholera, Vaxchora. It is the only single-dose vaccine for cholera currently licensed anywhere in the world. Read more

CONTINUING PHARMACY EDUCATION

The rundown: Management of acute and chronic diarrhea

This month's CE activity, "The rundown: Management of acute and chronic diarrhea," is open for pharmacists and pharmacy technicians.
The goal of this activity is to review the various risk factors, etiologies, and treatments of diarrhea as well as the pharmacist's role in its management.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Opioid patients lack access to treatment

In one of the largest studies of its kind, researchers found that nearly one-third (31.6%) of opioid use disorder (OUD) patients were receiving no opioid dependence treatment. Further, less than half (42.8%) of patients were prescribed medication-assisted treatment. Read more

June 17, 2016

Related Articles

FDA warns about OTC antacids, antidiarrheal med

FDA approves rare liver disease drug